Science Must Not Be Used to Foster White Supremacy
By Janet D. Stemwedel ,
The Scientific American
| 05. 24. 2022
Photo by Ousa Chea on Unsplash
The white supremacist who drove 200 miles to a Buffalo, N.Y., supermarket and opened fire, killing 10 people, had posted a screed. Most of the people he killed were Black. The document’s 180 pages cited not only racist conspiracy theories, but also scientific research on behavioral genetics. The research focused on finding heritable differences in IQ and propensity to violence between racial groups.
There’s no reason to believe, on the basis of his screed, that the Buffalo shooter understood, or even read, the scientific papers. It’s more likely that he collected them, like the racist tropes he reproduced in the document, from message boards and social media channels whose users latch on to titles that seem to promise scientific support for white supremacy. Scientists who research genetic bases for complex behavioral traits using genome-wide association studies have urged care in the conclusions drawn from population means, and especially in how their scientific results are communicated to general audiences. But there is compelling evidence that research on the evolution of sociobehavioral traits finds an...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...